Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
26.80
+0.89 (3.43%)
At close: Aug 10, 2026, 4:00 PM EDT
26.77
-0.03 (-0.11%)
Pre-market: Aug 11, 2026, 4:07 AM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI | Evercore ISI | Buy Maintains $33 | Buy | Maintains | $33 | +23.13% | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +86.57% | Aug 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 5, 2026 |
| Wedbush | Wedbush | Hold Maintains $30 | Hold | Maintains | $30 | +11.94% | Aug 5, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $96 | Buy | Maintains | $96 | +258.21% | Aug 5, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $67 | Buy | Maintains | $67 | +150.00% | Aug 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $40 | Buy | Maintains | $40 | +49.25% | Aug 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $79 → $81 | Buy | Maintains | $79 → $81 | +202.24% | Aug 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.